Medicare PSA Screening Coverage Guidelines To Be Finalized By 2000
This article was originally published in The Gray Sheet
Executive Summary
Development by the Health Care Financing Administration of coverage guidelines for prostate-specific antigen screening under the Medicare program is taking a backseat to other provisions of the Balanced Budget Act with earlier deadlines, according to the agency.
You may also be interested in...
USPSTF Drops Opposition To Prostate Screening, Remains Skeptical
The U.S. Preventive Services Task Force will no longer recommend against routine prostate cancer screening, but cautions that the benefits have not been fully demonstrated
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.